JW (Cayman) Therapeutics Co. Ltd.(DE:JNY)
€0.28+0.01 (+3.68%)
DE:JNY
JW (Cayman) Therapeutics Co. Ltd. Revenue
€0.28
At close:+0.01 (+3.68%)
JW (Cayman) Therapeutics Co. Ltd. (JNY) Revenue
0 Followers
JW (Cayman) Therapeutics Co. Ltd. Revenue
JW (Cayman) Therapeutics Co. Ltd. had a revenue of 111.48M in the quarter ending Jun 30, 2026, with -36.06%. This bring the company's revenue in the last twelve months to 285.83M, Increased 1.83%. In the fiscal year ending Dec 31, 2025, JW (Cayman) Therapeutics Co. Ltd. had annual revenue of 276.31M with 74.64% growth.
- Revenue (ttm)
- 285.83M
- Revenue Growth
- 55.89%
- P/S Ratio
- 0.45
- Revenue/Employee
- EUR 911,920
- Employees
- 303
- Market Cap
- EUR 124.88M
Revenue Chart
JW (Cayman) Therapeutics Co. Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 276.31M | 118.09M | 74.64% |
| Dec 31, 2024 | 158.22M | -15.64M | -8.99% |
| Dec 31, 2023 | 173.86M | 28.15M | 19.32% |
| Dec 31, 2022 | 145.70M | 114.91M | 373.10% |
| Dec 31, 2021 | 30.80M | 30.80M | ― |
| Dec 31, 2020 | 0.00 | -5.48M | -100.00% |
| Dec 31, 2019 | 5.48M | 5.27M | 2450.23% |
| Dec 31, 2018 | 215.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.